When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HGEN - Humanigen on go with COVID-19 study in Brazil
Humanigen Inc.
Brazil's Anvisa regulatory agency has signed off on a Phase 3 clinical trial evaluating Humanigen's (OTCQB:HGEN+2.4%) lead drug lenzilumab in hospitalized severely ill and critically ill COVID-19 patients at high risk of disease progression.
More news on: Humanigen, Inc., Healthcare stocks news, Stocks on the move,